AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to ...
AIM ImmunoTech (AIM) announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety of Ampligen in Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback